ANI Pharmaceuticals Inc (OQ:ANIP)

Latest 10 SEC filings (by transaction date) for ANIP within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET December 8th, 2023
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Nov 20/23 Nov 17/23 Shanmugam Muthusamy Indirect Ownership Common Stock S - Open market or private sale -13,000 $51.00
Nov 20/23 Nov 16/23 Shanmugam Muthusamy Indirect Ownership Common Stock S - Open market or private sale -6,448 $51.66
Nov 16/23 Nov 16/23 Shanmugam Muthusamy Indirect Ownership Common Stock S - Open market or private sale -6,448 $51.66
Nov 16/23 Nov 15/23 Davis Krista Direct Ownership Common Stock S - Open market or private sale -2,622 $53.81
Nov 20/23 Nov 15/23 Shanmugam Muthusamy Indirect Ownership Common Stock S - Open market or private sale -7,647 $53.64
Nov 16/23 Nov 15/23 Shanmugam Muthusamy Indirect Ownership Common Stock S - Open market or private sale -7,647 $53.64
Nov 20/23 Nov 14/23 Shanmugam Muthusamy Indirect Ownership Common Stock S - Open market or private sale -22,905 $53.17
Nov 16/23 Nov 14/23 Shanmugam Muthusamy Indirect Ownership Common Stock S - Open market or private sale -22,095 $53.17
Nov 13/23 Nov 10/23 Mutz Christopher Direct Ownership Common Stock S - Open market or private sale -3,000 $52.47
Oct 19/23 Oct 19/23 Shanmugam Muthusamy Indirect Ownership Common Stock S - Open market or private sale -10,000 $57.06
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for ANIP within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET December 8th, 2023
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Nov 20/23 Nov 17/23 Shanmugam Muthusamy Indirect Ownership Common Stock S - Open market or private sale -13,000 $51.00
Nov 20/23 Nov 16/23 Shanmugam Muthusamy Indirect Ownership Common Stock S - Open market or private sale -6,448 $51.66
Nov 20/23 Nov 15/23 Shanmugam Muthusamy Indirect Ownership Common Stock S - Open market or private sale -7,647 $53.64
Nov 20/23 Nov 14/23 Shanmugam Muthusamy Indirect Ownership Common Stock S - Open market or private sale -22,905 $53.17
Nov 16/23 Nov 15/23 Davis Krista Direct Ownership Common Stock S - Open market or private sale -2,622 $53.81
Nov 16/23 Nov 16/23 Shanmugam Muthusamy Indirect Ownership Common Stock S - Open market or private sale -6,448 $51.66
Nov 16/23 Nov 15/23 Shanmugam Muthusamy Indirect Ownership Common Stock S - Open market or private sale -7,647 $53.64
Nov 16/23 Nov 14/23 Shanmugam Muthusamy Indirect Ownership Common Stock S - Open market or private sale -22,095 $53.17
Nov 13/23 Nov 10/23 Mutz Christopher Direct Ownership Common Stock S - Open market or private sale -3,000 $52.47
Oct 19/23 Oct 19/23 Shanmugam Muthusamy Indirect Ownership Common Stock S - Open market or private sale -10,000 $57.06
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $ANIP

  • No tweets found

Competitors

Competitors with Recent Insider Filings
Eyepoint Pharmaceuticals (OQ:EYPT)
Amphastar Pharmaceuticals (OQ:AMPH)
AbbVie (N:ABBV)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.